Evidence map›Paper›PMID 28081129›Full record

ArticlePloS one2017

Effects of Kasugamycin on the Translatome of Escherichia coli.

Christian Lange, Matthias Lehr, Karolin Zerulla, Petra Ludwig, Jens Schweitzer, Tino Polen, Volker F Wendisch, Jörg Soppa

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Particulate matterRespiratory research · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Selective translation by alternative bacterial ribosomes.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Christian LangeGoethe University, Biocentre, Institute for Molecular Biosciences, Frankfurt, Germany.
Matthias LehrGoethe University, Biocentre, Institute for Molecular Biosciences, Frankfurt, Germany.
Karolin ZerullaGoethe University, Biocentre, Institute for Molecular Biosciences, Frankfurt, Germany.
Petra LudwigGoethe University, Biocentre, Institute for Molecular Biosciences, Frankfurt, Germany.
Jens SchweitzerGoethe University, Biocentre, Institute for Molecular Biosciences, Frankfurt, Germany.
Tino PolenUniversity of Bielefeld, Faculty of Biology, University of Bielefeld, Bielefeld, Germany.
Volker F WendischUniversity of Bielefeld, Faculty of Biology, University of Bielefeld, Bielefeld, Germany.
Jörg SoppaGoethe University, Biocentre, Institute for Molecular Biosciences, Frankfurt, Germany.
Goethe University Frankfurt · DEBielefeld University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is long known that Kasugamycin inhibits translation of canonical transcripts containing a 5'-UTR with a Shine Dalgarno (SD) motif, but not that of leaderless transcripts. To gain a global overview of the influence of Kasugamycin on translation efficiencies, the changes of the translatome of Escherichia coli induced by a 10 minutes Kasugamycin treatment were quantified. The effect of Kasugamycin differed widely, 102 transcripts were at least twofold more sensitive to Kasugamycin than average, and 137 transcripts were at least twofold more resistant, and there was a more than 100-fold difference between the most resistant and the most sensitive transcript. The 5'-ends of 19 transcripts were determined from treated and untreated cultures, but Kasugamycin resistance did neither correlate with the presence or absence of a SD motif, nor with differences in 5'-UTR lengths or GC content. RNA Structure Logos were generated for the 102 Kasugamycin-sensitive and for the 137 resistant transcripts. For both groups a short Shine Dalgarno (SD) motif was retrieved, but no specific motifs associated with resistance or sensitivity could be found. Notably, this was also true for the region -3 to -1 upstream of the start codon and the presence of an extended SD motif, which had been proposed to result in Kasugamycin resistance. Comparison of the translatome results with the database RegulonDB showed that the transcript with the highest resistance was leaderless, but no further leaderless transcripts were among the resistant transcripts. Unexpectedly, it was found that translational coupling might be a novel feature that is associated with Kasugamycin resistance. Taken together, Kasugamycin has a profound effect on translational efficiencies of E. coli transcripts, but the mechanism of action is different than previously described.

Indexed as

5' Untranslated RegionsBase CompositionAminoglycosidesDatabases, ProteinEscherichia coliEscherichia coli ProteinsProtein Biosynthesis5' Untranslated RegionsAminoglycosidesEscherichia coli Proteinskasugamycin

Identifiers

PMID28081129
PMCPMC5230787
OpenAlexW2578521756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.